A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme

Clinical trial NCT03025893 · UNKNOWN

Trial details

NCT number: NCT03025893
Sponsor: Amsterdam UMC, location VUmc
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Glioblastoma Multiforme Glioblastoma, Adult Glioblastoma Recurrent Brain Tumor GBM

Start date: 2018-08-31
Primary completion: 2022-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.